68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls.

Zohar KeidarRonit GillElinor GoshenOra IsraelTima DavidsonMaryna MorgulisNatalia PirmisashviliSimona Ben-Haim

Published in: Cancer imaging : the official publication of the International Cancer Imaging Society (2018)

The distribution of 68Ga-PSMA avid metastatic lesions is similar to data previously reported mainly from autopsy with comparable detection rates, indicating 68Ga-PSMA PET/CT is an accurate detection tool in patients with metastatic prostate cancer. If confirmed by further prospective studies 68Ga-PSMA PET/CT should be included in the guidelines to evaluate disease extent in these patients.

Keyphrases

pet ct
prostate cancer
end stage renal disease
positron emission tomography
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
squamous cell carcinoma
prognostic factors
patient reported outcomes
machine learning
high resolution
mass spectrometry
deep learning